BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27020659)

  • 21. The Ca(2+)-activated K(+) channel KCa3.1 compartmentalizes in the immunological synapse of human T lymphocytes.
    Nicolaou SA; Neumeier L; Peng Y; Devor DC; Conforti L
    Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1431-9. PubMed ID: 17151145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.
    Anumanthan G; Gupta S; Fink MK; Hesemann NP; Bowles DK; McDaniel LM; Muhammad M; Mohan RR
    PLoS One; 2018; 13(3):e0192145. PubMed ID: 29554088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered K
    Seo CH; Cui HS; Kim JB
    Transl Res; 2021 Oct; 236():133-146. PubMed ID: 33905948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K
    Robles-Martínez L; Garay E; Martel-Gallegos MG; Cisneros-Mejorado A; Pérez-Montiel D; Lara A; Arellano RO
    Sci Rep; 2017 Jun; 7(1):4340. PubMed ID: 28659615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration.
    Kaushal V; Koeberle PD; Wang Y; Schlichter LC
    J Neurosci; 2007 Jan; 27(1):234-44. PubMed ID: 17202491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans.
    Toyama K; Wulff H; Chandy KG; Azam P; Raman G; Saito T; Fujiwara Y; Mattson DL; Das S; Melvin JE; Pratt PF; Hatoum OA; Gutterman DD; Harder DR; Miura H
    J Clin Invest; 2008 Sep; 118(9):3025-37. PubMed ID: 18688283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Migration-associated secretion of melanoma inhibitory activity at the cell rear is supported by KCa3.1 potassium channels.
    Schmidt J; Friebel K; Schönherr R; Coppolino MG; Bosserhoff AK
    Cell Res; 2010 Nov; 20(11):1224-38. PubMed ID: 20733613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SK4 channels modulate Ca
    Steudel FA; Mohr CJ; Stegen B; Nguyen HY; Barnert A; Steinle M; Beer-Hammer S; Koch P; Lo WY; Schroth W; Hoppe R; Brauch H; Ruth P; Huber SM; Lukowski R
    Mol Oncol; 2017 Sep; 11(9):1172-1188. PubMed ID: 28557306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ca
    Ohya S; Kito H
    Biol Pharm Bull; 2018; 41(8):1158-1163. PubMed ID: 30068864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells.
    Ruggieri P; Mangino G; Fioretti B; Catacuzzeno L; Puca R; Ponti D; Miscusi M; Franciolini F; Ragona G; Calogero A
    PLoS One; 2012; 7(10):e47825. PubMed ID: 23110108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The calcium-activated potassium channel KCa3.1 plays a central role in the chemotactic response of mammalian neutrophils.
    Henríquez C; Riquelme TT; Vera D; Julio-Kalajzić F; Ehrenfeld P; Melvin JE; Figueroa CD; Sarmiento J; Flores CA
    Acta Physiol (Oxf); 2016 Jan; 216(1):132-45. PubMed ID: 26138196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
    Hansen LK
    Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ion channels in control of pancreatic stellate cell migration.
    Storck H; Hild B; Schimmelpfennig S; Sargin S; Nielsen N; Zaccagnino A; Budde T; Novak I; Kalthoff H; Schwab A
    Oncotarget; 2017 Jan; 8(1):769-784. PubMed ID: 27903970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orai/CRACM1 and KCa3.1 ion channels interact in the human lung mast cell plasma membrane.
    Duffy SM; Ashmole I; Smallwood DT; Leyland ML; Bradding P
    Cell Commun Signal; 2015 Jul; 13():32. PubMed ID: 26177720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SK4 oncochannels regulate calcium entry and promote cell migration in KRAS-mutated colorectal cancer.
    Ibrahim S; Chaigne J; Dakik H; Fourbon Y; Corset L; Lecomte T; Raoul W; Guéguinou M
    Cell Calcium; 2021 Jun; 96():102384. PubMed ID: 33676318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma.
    Brown BM; Pressley B; Wulff H
    Curr Neuropharmacol; 2018; 16(5):618-626. PubMed ID: 28676010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Podosomes, But Not the Maturation Status, Determine the Protease-Dependent 3D Migration in Human Dendritic Cells.
    Cougoule C; Lastrucci C; Guiet R; Mascarau R; Meunier E; Lugo-Villarino G; Neyrolles O; Poincloux R; Maridonneau-Parini I
    Front Immunol; 2018; 9():846. PubMed ID: 29760696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complementary roles of KCa3.1 channels and β1-integrin during alveolar epithelial repair.
    Girault A; Chebli J; Privé A; Trinh NT; Maillé E; Grygorczyk R; Brochiero E
    Respir Res; 2015 Sep; 16(1):100. PubMed ID: 26335442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating CFTR and KCa3.1 Protein/Protein Interactions.
    Klein H; Abu-Arish A; Trinh NT; Luo Y; Wiseman PW; Hanrahan JW; Brochiero E; Sauvé R
    PLoS One; 2016; 11(4):e0153665. PubMed ID: 27092946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke.
    Chen YJ; Wallace BK; Yuen N; Jenkins DP; Wulff H; O'Donnell ME
    Stroke; 2015 Jan; 46(1):237-44. PubMed ID: 25477223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.